We are live on ! Find out more
AIA

Avalon Investment & Advisory Portfolio holdings

AUM $3.65B
1-Year Est. Return 0.47%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+0.47%
3 Year Est. Return
+93.46%
5 Year Est. Return
+110.61%
10 Year Est. Return
+307.63%
AUM
$2.77B
AUM Growth
+$113M
Cap. Flow
+$55.2M
Cap. Flow %
1.99%
Top 10 Hldgs %
21.53%
Holding
367
New
64
Increased
117
Reduced
145
Closed
37

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$13.3M
2
MET icon
MetLife
MET
+$13.1M
3
IBM icon
IBM
IBM
+$10.5M
4
ADP icon
Automatic Data Processing
ADP
+$10M
5
BBY icon
Best Buy
BBY
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 13.43%
2 Financials 12.62%
3 Healthcare 12.01%
4 Energy 10.9%
5 Consumer Staples 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
101
DELISTED
Pioneer Natural Resource Co.
PXD
$9.49M 0.34%
52,726
-442
-0.8% -$81K
COST icon
102
Costco
COST
$420B
$8.96M 0.32%
55,975
-1,893
-3% -$289K
DHR icon
103
Danaher
DHR
$137B
$8.74M 0.32%
126,676
-3,049
-2% -$212K
UNP icon
104
Union Pacific
UNP
$176B
$8.65M 0.31%
83,424
-1,836
-2% -$181K
GM icon
105
General Motors
GM
$77.5B
$8.63M 0.31%
247,828
-6,559
-3% -$220K
NWL icon
106
Newell Brands
NWL
$2.61B
$8.6M 0.31%
192,639
-7,983
-4% -$386K
ROST icon
107
Ross Stores
ROST
$80.5B
$8.04M 0.29%
122,506
-3,009
-2% -$197K
TJX icon
108
TJX Companies
TJX
$174B
$7.59M 0.27%
202,020
-4,628
-2% -$175K
SBUX icon
109
Starbucks
SBUX
$120B
$7.58M 0.27%
136,592
+8,961
+7% +$496K
ORCL icon
110
Oracle
ORCL
$420B
$7.36M 0.27%
191,340
-20,854
-10% -$816K
AWH
111
DELISTED
Allied World Assurance Co Hld Lt
AWH
$7.15M 0.26%
+133,057
New +$6.11M
GILD icon
112
Gilead Sciences
GILD
$168B
$7.06M 0.25%
98,621
+2,626
+3% +$195K
BMY icon
113
Bristol-Myers Squibb
BMY
$135B
$6.69M 0.24%
114,531
-11,864
-9% -$649K
BBY icon
114
Best Buy
BBY
$18.2B
$6.67M 0.24%
+156,328
New +$6.64M
SPGI icon
115
S&P Global
SPGI
$122B
$6.67M 0.24%
61,995
-4,727
-7% -$565K
ECL icon
116
Ecolab
ECL
$79.7B
$6.58M 0.24%
56,121
-1,284
-2% -$150K
AGN
117
DELISTED
Allergan plc
AGN
$6.58M 0.24%
31,319
-1,636
-5% -$339K
WBA
118
DELISTED
Walgreens Boots Alliance
WBA
$6.5M 0.23%
78,510
-2,649
-3% -$219K
PX
119
DELISTED
Praxair Inc
PX
$6.45M 0.23%
55,011
-2,272
-4% -$270K
MCO icon
120
Moody's
MCO
$83.8B
$6.44M 0.23%
68,355
-5,090
-7% -$514K
CVS icon
121
CVS Health
CVS
$133B
$6.36M 0.23%
80,565
-4,600
-5% -$372K
COP icon
122
ConocoPhillips
COP
$144B
$6.31M 0.23%
125,790
+105,272
+513% +$4.85M
GEN icon
123
Gen Digital
GEN
$16.9B
$5.94M 0.21%
+248,464
New +$6.1M
EMR icon
124
Emerson Electric
EMR
$89B
$5.55M 0.2%
+99,529
New +$5.35M
ACN icon
125
Accenture
ACN
$104B
$5.16M 0.19%
+44,057
New +$5.23M

Similar funds

Avalon Investment & Advisory's Q4 2016 Portfolio in Review

As of Q4 2016, Avalon Investment & Advisory held 367 positions worth $2.77B, up 4.2% from $2.66B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Avalon Investment & Advisory's Q4 2016 filing shows 64 new, 117 increased, 145 reduced and 37 closed positions. Its largest new stake was Eli Lilly: 177,976 shares worth $13.1M. The largest sale was Reynolds American Inc, an estimated $14.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Avalon Investment & Advisory's largest Q4 2016 buy was Eli Lilly: 177,976 shares worth $13.1M.
  • Avalon Investment & Advisory added most to MetLife in Q4 2016, an estimated $13.1M increase.
  • Avalon Investment & Advisory's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $14.2M.
  • Avalon Investment & Advisory fully exited Mid-America Apartment Communities in Q4 2016, selling an estimated $12.7M.
  • Avalon Investment & Advisory's ten largest holdings make up 22% of its $2.77B portfolio in Q4 2016.
  • Avalon Investment & Advisory opened 64 new positions and closed 37 in Q4 2016.
  • Avalon Investment & Advisory's portfolio value rose 4.2% quarter-over-quarter to $2.77B.

Based on Avalon Investment & Advisory's 13F filing for Q4 2016, filed 14 Feb 2017.